Dr. Draulio Barros de Araujo is a 1995 graduate of the University of Brasilia with a degree in physics, and he completed his Ph.D in physics applied to medicine and biology, working with functional neuroimaging tools, in 2002 at the University of Sao Paulo. From 2009 to present, Dr. Draulio has been a professor (associate) of neuroscience at the Brain Institute of the University of Rio Grande do Norte (UFRN) in Brazil. From 2017 to 2019 Dr. Draulio held the position of visiting scholar at the Department of Psychological and Brain Sciences of the University of California in United States.
Since 2006 Dr. Draulio’s research has focused on using functional neuroimaging methods (EEG and fMRI) to investigate the acute and lasting effects of the psychedelic Ayahuasca.
In 2016, Dr. Draulio completed the first controlled trial to test a psychedelic substance (ayahuasca) in treatment-resistance depression, the results of which support the safety and therapeutic value of ayahuasca to address treatment-resistant depression. This study is registered at http://clinical trials.gov (NCT02914769). Dr. Draulio’s trial was Sponsored by University of Sao Paulo and had, as a trial collaboration partner, UFRN, two of the most prestigious universities in Brazil.